Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting?

OBJECTIVE Recent studies have demonstrated that statins have pleiotropic effects, including anti-inflammatory effects and atrial fibrillation (AF) preventive effects. The objective of this study was to assess the efficacy of preoperative statin therapy in preventing AF after coronary artery bypass grafting (CABG). METHODS 221 patients underwent CABG in our hospital from 2004 to 2007. 14 patients with preoperative AF and 4 patients with concomitant valve surgery were excluded from this study. Patients were divided into two groups to examine the influence of statins: those with preoperative statin therapy (Statin group, n = 77) and those without it (Non-statin group, n = 126). In addition, patients were divided into two groups to determine the independent predictors for postoperative AF: those with postoperative AF (AF group, n = 54) and those without it (Non-AF group, n = 149). Patient data were collected and analyzed retrospectively. RESULTS The overall incidence of postoperative AF was 26%. Postoperative AF was significantly lower in the Statin group compared with the Non-statin group (16% versus 33%, p = 0.005). Multivariate analysis demonstrated that independent predictors of AF development after CABG were preoperative statin therapy (odds ratio [OR] 0.327, 95% confidence interval [CI] 0.107 to 0.998, p = 0.05) and age (OR 1.058, 95% CI 1.004 to 1.116, p = 0.035). CONCLUSION Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.

[1]  G. Moneta,et al.  Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein , 2009 .

[2]  J. Mathew,et al.  A multicenter risk index for atrial fibrillation after cardiac surgery. , 2004 .

[3]  S. Kitamura,et al.  Perioperative advantages of off-pump coronary artery bypass grafting. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[4]  Paul Schoenhagen,et al.  Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. , 2005, The New England journal of medicine.

[5]  S. Body,et al.  Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. , 1998, Anesthesiology.

[6]  Shengshou Hu,et al.  Increasing Long-Term Major Vascular Events and Resource Consumption in Patients Receiving Off-Pump Coronary Artery Bypass: A Single-Center Prospective Observational Study , 2010, Circulation.

[7]  F. Musumeci,et al.  Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. , 2008, The Journal of thoracic and cardiovascular surgery.

[8]  V. Pasceri,et al.  Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) Study , 2006, Circulation.

[9]  J. Mathew,et al.  A multicenter risk index for atrial fibrillation after cardiac surgery. , 2004, JAMA.

[10]  Yu Zhang,et al.  Pretreatment with statins enhances myocardial protection during coronary revascularization. , 2003, The Journal of thoracic and cardiovascular surgery.

[11]  L. Cohn,et al.  Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. , 1996, Circulation.

[12]  C. To.  Predictors of atrial fibrillation after coronary artery surgery. , 1997 .

[13]  M. Caputo,et al.  Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. , 2009, The Annals of thoracic surgery.

[14]  Paul Schoenhagen,et al.  Determinants of Arterial Wall Remodeling During Lipid-Lowering Therapy: Serial Intravascular Ultrasound Observations From the Reversal of Atherosclerosis With Aggressive Lipid Lowering Therapy (REVERSAL) Trial , 2006, Circulation.

[15]  A. Keech,et al.  Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. , 2006, European heart journal.

[16]  P. Mills,et al.  Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. , 2000, Circulation.

[17]  I. Ali,et al.  Beta-blocker effects on postoperative atrial fibrillation. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  C. Klersy,et al.  Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. , 2007, The Annals of thoracic surgery.

[19]  W. Cohn,et al.  In-hospital outcomes of off-pump versus on-pump coronary artery bypass procedures: a multicenter experience. , 2001, The Annals of thoracic surgery.

[20]  M. Banach,et al.  Risk factors of atrial fibrillation following coronary artery bypass grafting: a preliminary report. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[21]  C. White,et al.  Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. , 2008, The Journal of thoracic and cardiovascular surgery.

[22]  R. Erbel,et al.  Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery. , 2007, The Journal of thoracic and cardiovascular surgery.